Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli
Dagsetning
Höfundar
Journal Title
Journal ISSN
Volume Title
Útgefandi
Útdráttur
In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit.
Lýsing
Publisher Copyright: © 2023 Laeknafelag Islands. All rights reserved.
Efnisorð
ADHD, methylphenidate, psychosis, ADHD, methylphenidate, psychosis, Young Adult, Central Nervous System Stimulants/adverse effects, Humans, Methylphenidate/adverse effects, Male, Psychotic Disorders/diagnosis, Iceland/epidemiology, Attention Deficit Disorder with Hyperactivity/diagnosis, General Medicine
Citation
Gudbrandsdottir, R K, Sigurðsson, E & Ingimarsson, O 2023, 'Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli', Læknablaðið, vol. 109, no. 7-8, pp. 346-349. https://doi.org/10.17992/lbl.2023.0708.753